Detection of fungal DNA in lysis–centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients  by Trovato, L. et al.
Detection of fungal DNA in
lysis–centrifugation blood culture
for the diagnosis of invasive candidiasis
in neonatal patients
L. Trovato1, P. Betta2, M. G. Romeo2 and S. Oliveri1
1) Department of Bio-Medical Science, University of Catania, Laboratory
Analysis Unit and 2) Department of Mother and Child, University of Cata-
nia, Neonatal Intensive Care Unit, Policlinico ‘G. Rodolico’, Catania, Italy
Abstract
We report data concerning the detection of fungal DNA directly
from lysis–centrifugation blood culture to assess its value in the
detection of fungaemia in 86 of the 347 patients admitted to the
neonatal intensive-care unit between January 2009 and December
2010. The sensitivity and speciﬁcity of the PCR were 87.5% and
98.5%, respectively, with a positive predictive value of 93.3% and
a negative predictive value of 97.1%. Detection of fungal DNA
directly from blood culture Isolator 1.5 microbial tubes, without
prior cultivation, is a promising approach for the rapid detection
of Candida spp. in neonates with suspected candidaemia.
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Preterm neonates in neonatal intensive-care units (NICUs)
are at high risk of acquiring invasive fungal infections (IFIs),
mostly by Candida spp. IFIs in such patients are increasingly
leading to high morbidity and mortality, and frequent neuro-
developmental disabilities in the survivors [1,2]. Neonatal IFIs
are difﬁcult to diagnose, as candidaemia may be transient and
difﬁcult to eradicate, owing to the high rates of end-organ
dissemination. Diagnosis is still based mostly on blood
cultures; however, blood cultures are thought to be positive
for Candida in only 24–60% of cases [3,4]. In septic neonates,
phlebotomy may be difﬁcult, and the small volume of blood
obtained for culture may limit sensitivity. Blood culture
detection of candidaemia may take 48 h or more, and some
cases of systemic candidiasis are not diagnosed until autopsy
[5]. In view of these limitations, other techniques for facilitat-
ing the diagnosis of IFI have been investigated. Recently,
determination of circulating antigens and determination of
fungal DNA have been considered to be the most convenient
non-culture methods for the diagnosis of IFIs and monitoring
of antifungal treatment [6].
In particular, several molecular methods for the detection
of fungaemia in blood samples or directly from blood culture
bottles, such as PCR, semi-nested PCR, and real-time PCR,
have been developed [7–10].
In this article, we report data concerning the detection of
fungal DNA directly from lysis–centrifugation blood culture,
without prior cultivation, to assess its value in the detection
of fungaemia in NICU patients with suspected bloodstream
infections. Proven candidiasis was deﬁned, in the present
study, as a positive culture from blood (drawn from periph-
eral sites). Probable candidiasis was deﬁned as clinical wors-
ening with septic features conﬁrmed by laboratory data
(increase in serum C-reactive protein levels, leukocytosis,
and neutrophilia), despite aggressive broad-spectrum antibi-
otic therapy for at least 2 days, with no isolation of other
microorganisms in any cultures in the previous 2 days, in
neonates who have heavy Candida intestinal colonization and
an improvement in clinical symptoms following administration
of antifungal drugs [11]. Proven candidiasis was observed in
eight of the 347 neonates admitted to the NICU between
January 2009 and December 2010, a frequency of 2.3%.
Eighty-six neonates were included in this study, on the basis
of the clinical conditions and high risk of invasive candidiasis,
including the use of broad-spectrum antibiotics and paren-
teral nutrition, or the use of invasive management such as
central venous catheters or endotracheal tubes [12,13].
For the blood cultures, Isolator 1.5 microbial tubes
(Wampole Laboratories, Princeton, NJ, USA) were used to
perform both the culture and detection of fungal DNA on
the same sample. From 1.0 to 1.2 mL of blood was with-
drawn. The tubes were initially agitated mechanically by vor-
texing to facilitate the lysis of blood cells. Then, 0.5–0.7 mL
of blood was inoculated on a blood agar plate and Sabouraud
dextrose agar with chloramphenicol and gentamicin, and
0.5 mL was aseptically transferred to a 15-mL centrifuge tube
and treated for DNA extraction. Water was added up to a
volume of 12 mL, and the tubes were placed in ice for
10 min. After centrifugation, the pellets were treated with
lysis buffer (10 mM Tris (pH 7.6), 5 mM MgCl2, 10 mM
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NaCl, 150 mg/mL proteinase K (Boehringer Mannheim, India-
napolis, IN, USA)) for 45 min at 65C. After centrifugation,
DNA extraction was performed with the DNeasy Plant Mini
Kit (Qiagen, Hilden, Germany), according to the manufac-
turer’s instructions. The fungus-speciﬁc universal primers
ITS1 and ITS2 were used to amplify a small conserved por-
tion of the 18S rDNA region, the adjacent ITS1, and a small
portion of the 28S rDNA region [14]. PCR was performed
in a total reaction volume of 50 lL consisting of 2 ng of tem-
plate DNA, 1.5 mM MgCl2, 0.8 mM dNTPs (0.2 mM each),
10 · PCR buffer, 1 lM (0.5 lM each), and Taq DNA poly-
merase (1.25 U). PCR was carried out with a Veriti 96-well
Thermal Cycler under the following conditions: initial dena-
turation at 95C for 15 min; 40 cycles of denaturation
(94C, 1 min), annealing (60C, 45 s), and extension (72C,
1 min); and a ﬁnal extension at 72C for 10 min. The PCR
products were analysed on ethidium bromide-stained 2%
agarose gels (Fig. 1). In three independent experiments, the
limit of detection of PCR for Candida albicans ATCC 2129
artiﬁcially inoculated in whole blood was 10–30 CFU/mL.
The neonates with proven/probable candidiasis and with-
out candidiasis had the following characteristics (mean ±
standard deviation), respectively: gestational age, 30.81 ±
3.48 weeks and 34.9 ± 2.46 weeks; and birthweight,
1124 ± 249 g and 2208 ± 458 g. The other characteristics
and test results of neonates with proven or probable candi-
diasis, or without candidiasis, are summarized in Table 1.
For the neonate with positive blood culture and a nega-
tive fungal PCR ﬁnding, DNA extraction was performed
with 0.1 mL of blood. In one neonate with negative blood
culture and without candidiasis, a positive fungal PCR ﬁnd-
ing was obtained. One neonate with negative blood culture
and a negative fungal PCR ﬁnding was considered to be
suffering from probable candidiasis. On the basis of these
results, the sensitivity and speciﬁcity of PCR for cases of
proven or probable candidiasis were 87.5% and 98.5%,
respectively. The positive predictive value and negative
predictive value were 93.3% and 97.1%, respectively. For
the eight cases of proven candidiasis, the sensitivity was
87.5%, the speciﬁcity was 89.7%, the positive predictive
value was 46.6%, and the negative predictive value was
98.6%.
In conclusion, the use of a lysis–centrifugation system
improves the diagnosis of fungaemia [15] and probably also
the detection of fungal DNA, despite the low volume of
blood available as a result of the presence in the tube
of saponin, which is a powerful lysing agent. In fact, in seven
of the 16 patients (43.7%) with probable candidiasis, the diag-
nosis was supported by positive PCR ﬁndings, without the
performance of another blood collection. Furthermore, the
PCR results do not appear to be inﬂuenced by the start of
antifungal therapy, which, in these patients, is often initiated
before blood collection. This, in part, may explain the differ-
ence between the results of blood cultures and PCR. Detec-
tion of fungal DNA directly from blood cultures in
Isolator 1.5 microbial tubes, without prior cultivation, is a
promising approach for the rapid detection of Candida spp.
in neonates with suspected candidaemia. Furthermore, this
method needs only a tiny amount of blood from such very
small patients.
FIG. 1. PCR results from blood cultures in Isolator 1.5 microbial
tubes. M: 100-bp molecular marker. Lanes 1 and 6: PCR-negative
specimens. Lanes 2, 3, 4 and 5: PCR-positive specimens. Lane 7: posi-
tive control (Candida albicans ATCC 2129). Lane 8: negative control.
TABLE 1. Characteristics and test results of neonates with and without proven/probable candidiasis
No. of
newborns M/F
Mechanical
ventilation
Parenteral
nutrition
Positive blood
culture
Negative blood
culture
<15 days >15 days <15 days >15 days
Positive
PCR
Negative
PCR
Positive
PCR
Negative
PCR
Proven and probable candidiasis 16 6/10 9 7 3 11 7 1 7 1
Without candidiasis 70 32/38 22 0 48 0 0 0 1 69
F, female; M, male.
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